Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Assertio Therapeutics, Inc.
|
| gptkbp:focusesOn |
neurology
pain management |
| gptkbp:founded |
1995
|
| gptkbp:founder |
John W. Fara
|
| gptkbp:headquartersLocation |
gptkb:Newark,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Depomed, Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Nucynta
gptkb:Cambia gptkb:Zipsor gptkb:Gralise |
| gptkbp:renamed |
Assertio Therapeutics, Inc.
|
| gptkbp:tradedOn |
NASDAQ:DEPO
|
| gptkbp:website |
https://www.depomed.com/
|
| gptkbp:bfsParent |
gptkb:Proquin_XR
|
| gptkbp:bfsLayer |
6
|